Clinical trials
Vaginitis clinical trials
Below are recruiting vaginitis clinical trials, each written for real people, not researchers. We’re tracking 232 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05206682Recruiting
Treating C-section scar defect with hormones versus surgery alone
This trial compares two treatments for a pregnancy-related problem in the uterus: vaginal repair alone versus vaginal repair plus leuprorelin (a hormone medicine). It aims to improve symptoms like long or heavy bleeding when a C-section scar defect is also linked with adenomyosis.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT04046900RecruitingPhase 1/Phase 2
Fecal-style transplant of vaginal microbiome for recurring BV
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
Boston, MassachusettsAges 18–50 - NCT03785288RecruitingPhase 3
Testing different schedules of vaginal radiation after hysterectomy
This trial compares different “fractionation” schedules (how often and how many treatments) of vaginal brachytherapy radiation given after surgery for certain early-stage endometrial cancer. It may help find a plan that works well while aiming to control side effects.
Baltimore, MarylandAges 18 years+ - NCT02471443Recruiting
Laparoscopic surgery for severe endometriosis involving bowel
This trial studies how well a minimally invasive (laparoscopic) surgery works for people with severe endometriosis that affects the bowel. It may help improve symptoms and quality of life, and it focuses on planned surgery for this specific type of endometriosis.
Guildford, SurreyAges Any age - NCT05242861Recruiting
Reviewing outcomes after brachytherapy for women’s cancers
This study looks back at medical records to understand results after brachytherapy (a form of cancer radiation delivered from inside or close to the tumor) in women with gynecologic cancer. It may help doctors improve future treatment decisions, but you would not have to receive an experimental treatment.
Hangzhou, ZhejiangAges 18–80 - NCT03617133RecruitingPhase 2
MRI-guided radiation plus chemo for cervical cancer
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
ViennaAges 18–99 - NCT05682989Recruiting
Testing mesh surgery for pelvic organ prolapse symptoms
This trial studies how well and how safely a synthetic mesh surgery works for people with pelvic organ prolapse, especially when it causes bladder or urinary problems. It may help find better symptom relief, but it also tracks side effects closely.
New Taipei CityAges 30–100 - NCT05127252Recruiting
Study how gut bacteria may affect time to pregnancy
This study looks at whether differences in the gut (microbiome) are linked to how long it takes to get pregnant and pregnancy outcomes. It may help researchers understand who might benefit from future microbiome-focused approaches.
Stockholm, HuddingeAges 18–40 - NCT05968794Recruiting
Cervix stitch to help twin pregnancy with short cervix
This study tests whether placing a “cervix stitch” (cerclage) can reduce the risk of very early birth in twin pregnancies. It is for people whose cervix is shorter than expected or has started to open before 24 weeks.
AntwerpAges 16 years+ - NCT05371353Recruiting
Study of how long HPV vaccine immunity lasts
This study checks how well the HPV (cancer-preventing) vaccine protection stays in your body over time. It may help confirm the vaccine’s “long-lasting” immune response and guide future vaccination confidence.
Yangchun, GuangdongAges 9–45 - NCT07846527Recruiting
Study of a vaginal retraction device during gynecological exams
This study tests a device called VuSleeve that helps hold the vaginal walls during a gynecological exam or procedure. It may make exams more comfortable and easier for doctors to see clearly.
Aurora, ColoradoAges 21–65 - NCT04422366RecruitingPhase 3
9-valent HPV vaccine study for healthy Chinese women
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
Liuzhou, GuangxiAges 20–45 - NCT07818850Recruiting
Safety and imaging feasibility of a vagina-view device
This study tests a new tool that uses MRI to take images inside the vagina during brachytherapy (a type of radiation therapy) for gynecological cancer. The goal is to see if it is safe and helps doctors place the radiation better.
Toronto, OntarioAges 18 years+ - NCT07799857Recruiting
Light therapy for pelvic pain registry
This study tracks people getting light therapy inside the vagina for chronic pelvic pain. It helps doctors learn if this treatment works and who it helps most.
Melbourne, FloridaAges 18 years+ - NCT06544720RecruitingPhase 1
SCG142 TCR-T cell therapy for HPV-related cancers
This trial tests a new treatment called SCG142 TCR-T cells for cancers caused by HPV. The therapy uses your own immune cells to fight the tumor. It may help if other treatments haven't worked or are not available.
Qingdao, ShandongAges 18 years+ - NCT06051201Recruiting
ReceptIVFity test for IVF success prediction
This trial studies a vaginal swab test called ReceptIVFity that looks at the bacteria in your vagina to see if it can help predict how well IVF will work. You can join if you're about to start your first IVF cycle, are not on hormonal birth control or antibiotics, and your IVF is not for emergency reasons.
RotterdamAges 18–42 - NCT06509503RecruitingPhase 4
Effect of birth control pills on migraine
This study tests how combined oral contraceptive pills affect migraine in women. It will compare people who take these pills with those using non-hormonal methods like an IUD, to see if the pills help or change the migraine pattern.
Kafr ash ShaykhAges 18–55 - NCT07717502Recruiting
Comparing two ways to ripen the cervix for labor induction
This trial tests two different methods of preparing the cervix for labor induction in first-time mothers. The goal is to see which approach is more likely to lead to a vaginal delivery.
New Orleans, LouisianaAges 18 years+ - NCT07714902Recruiting
Calcium gluconate to reduce bleeding during vaginal birth
This study tests if giving calcium gluconate during childbirth can reduce blood loss. It might help women having a vaginal delivery after 37 weeks of pregnancy.
HaifaAges 18 years+ - NCT07669584RecruitingPhase 2/Phase 3
Testing PKB171 for mild male infertility in couples
This study tests a new oral medication (PKB171) compared to a placebo for couples who have mild male infertility and have not tried IVF/ICSI before. The goal is to see if PKB171 can help them conceive naturally.
Pamplona, NavarreAges 18–38 - NCT06673875Recruiting
Pelvic floor training for stress urinary incontinence
This study tests whether special pelvic floor muscle exercises using modern tools can help women with stress urinary incontinence (leaking urine when you cough, sneeze, or exercise). It may offer a non-surgical way to strengthen the muscles that control urine flow.
Brno, Czech RepublicAges 18–80 - NCT07667192Recruiting
Re-treating gynecologic cancer with repeat radiation or ablation
This trial studies using additional radiation or tumor-destroying techniques for gynecologic cancer that has come back after previous radiation treatment. It helps doctors understand if this approach is safe and effective for women with recurrent disease.
Zamość, Lublin VoivodeshipAges 18 years+ - NCT06671210Recruiting
Urine HPV testing for men
This study is testing whether a urine test can detect human papillomavirus (HPV) in men. HPV is a common virus that can cause certain cancers. The goal is to see if a simple urine test works as well as other methods. If you are an adult male who has been sexually active, this study may be an option.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06686043RecruitingPhase 2
HPV vaccine, imiquimod, and metformin for advanced cervical or vulvar cancer
This trial tests a combination of an HPV vaccine, an immune cream (imiquimod), and a diabetes drug (metformin) together with standard chemoradiation. The goal is to see if this mix helps treat advanced cervical, vaginal, or vulvar cancers better than standard care alone.
Houston, TexasAges 18–64
Hear when a new Vaginitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for vaginitis?
- Yes. Clin2 currently lists 232 recruiting vaginitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a vaginitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a vaginitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.